echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Well-known pharmaceutical company fined 32.07 million for adding extracts illegally

    Well-known pharmaceutical company fined 32.07 million for adding extracts illegally

    • Last Update: 2022-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 4, 2021, Guizhou Braun Group issued an announcement that its subsidiary, Herentang Pharmaceutical, was fined RMB 32,068,379.


    01 Production process is illegal

    01 Production process is illegal

    Company announcement shows that recently, Guizhou Braun Enterprise Group Pharmaceutical Co.


    When Herentang Pharmaceutical produces the drug "Kangfuling Capsules", it illegally extracts the cork extract powder and adds it to ensure that the product content meets the standard requirements


    02 illegal facts

    02 illegal facts

    The Guiyang Municipal Market Supervision Administration's announcement on the punishment of the case of Herentang Pharmaceutical Co.


    After discussion, it was decided to extract Phellodendron chinense according to the extraction process of Kangfuling capsule Chinese medicinal materials and store it in the buffer room of the logistics channel of the Herentang capsule production workshop.


    In the process of using the capsule production line to produce Kangfuling capsules, Herentang inspects the first batch of intermediate products using the same batch of raw cork.


    After investigation, from May 2018 to January 2019, a total of 36 batches of Kangfuling capsules were supplemented with cork dry ointment powder in violation of regulations (33 batches of finished products and 3 batches of closed finished products)


    The company illegally joined the 33 batches of Kangfuling capsules produced by the dry extract powder of Phellodendron chinense, a total of 1532030 boxes, of which 15 boxes were sampled by the former Guizhou Food and Drug Administration, and 135 boxes were used by employees; the remaining 1531880 boxes have been sold


    03 Half of the revenue was confiscated due to illegality

    03 Half of the revenue was confiscated due to illegality

    In view of the fact that Herentang Pharmaceuticals violated the law for the first time and voluntarily recalled the batch of products involved, and has not received any new adverse reaction report of the batch of products involved, it complies with Article 32, Paragraph 1, Article 32 of the Administrative Punishment Law of the People’s Republic of China.


    At the same time, it actively cooperated with Rentang Pharmaceutical Co.


    According to regulations, the Guiyang City Market Supervision Administration ordered Herentang Pharmaceutical to immediately stop the illegal activities, and imposed reduced administrative penalties as follows:

    1.


    2.


    Public information shows that Kangfuling Capsule is the exclusive product of Herentang Pharmaceutical


    Coincidentally, on November 19, 2021, Guangxi Jinhaitang Pharmaceutical Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.